Abstract
From the title of this symposium and the distribution of papers, one might mistakenly conclude that artificial liver and artificial kidney development were proceeding in parallel. In fact, progress in these two areas is decades apart. Artificial kidney devices are a standard form of therapy which is currently sustaining the lives of more than 20,000 people in the United States alone (1). In contrast, the sum total of all patients in hepatic failure ever treated with any experimental hepatic support device appears to be approximately 200. Moreover, analysis of the available data on the minority of survivors leaves uncertain the extent to which the devices employed contributed to their recovery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
